Solutions

Solutions

Our solutions span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or large global programs.

Read more

Cardiac Safety Solutions Clinical & Scientific Operations Consulting Early Clinical Laboratories Language Services Medical Imaging Site & Patient Solutions Strategic Solutions Symphony Health Technologies

Decentralised Clinical Trial Solutions
End-to-end services, operational model and technology to deliver customised solutions.

Real World Intelligence®
Optimising real world data to drive effective outcomes and achieve regulatory authorisation.
Sectors

Sectors

ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

Read more

Biotech Government and Public Health Medical Device Pharmaceuticals

Biotech
Developing transformative therapies requires a flexible approach.

ICON and You
Partners making a difference.
Therapeutics

Therapeutics

Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Infectious Diseases Internal Medicine & Immunology Oncology

Cross-therapeutics

Biosimilars Cell and Gene Therapies Medical Device Paediatrics Rare & Orphan Diseases Vaccines Women's Health

Obesity
A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

Therapeutics insights
ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.
Insights

Insights

Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel

Diversity and inclusion in clinical trials
Establishing a platform for improvement

Advancements in AI for site selection
Using human-enabled AI to enhance decision-making and minimise risk.

Optimising Biotech funding
Options for biotech to maximise their funds and improve their asset development program.
News & Events

News & Events

ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

Read more

Press releases In the News Mediakit Awards Events Webinars Social media

Webinar: Unlocking precision medicine: An overview of Illumina’s TSO500
17 June 2024

Webinar: Ensuring patient recruitment success at a site level
09 July 2024
About ICON

About ICON

Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life.

Read more

Company history Healthcare Intelligence ICON in Asia Pacific ICON in Latin America Leadership Quality

Environmental, Social and Governance
ICON CARES is our commitment to making a positive impact on our people, environment and our community.

Healthcare Intelligence
Clinical Research. Evolved.

Careers
Investors
Investigators
Patients
Contact

Home
Insights
ICON Webinar Channel

ICON Webinar Channel

Home
Clinical Research Services
Commercialisation & Outcomes
Early Phase
Laboratory Webinars
Medical Device
Therapeutic Webinars

Webinar - Regulatory submission writing for NDA sucess

1:00:10

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Description

Share

Share on Facebook
Share on X
Share on LinkedIn
Share via Email

Related Videos

In Latest Webinars

Play video Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500

Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500

57:36
Play video Global Clinical Trials Day: Digital Week - Day 2 Panel

Global Clinical Trials Day: Digital Week - Day 2 Panel

57:36
Play video Webinar: Mastering RMPs and RMMs

Webinar: Mastering RMPs and RMMs

57:08
Play video Webinar: Survival Analysis for Immature Data - A Review of Techniques and Lessons Learned

Webinar: Survival Analysis for Immature Data - A Review of Techniques and Lessons Learned

1:00:28
Play video Artificial Intelligence in Clinical Research

Artificial Intelligence in Clinical Research

34:42
Play video Webinar: Considerations for Oligonucleotide Therapeutics in CMC

Webinar: Considerations for Oligonucleotide Therapeutics in CMC

1:01:14

Contact
About ICON
Results & Reports

For Clients

Therapeutics
Solutions
Insights
Technologies
Content preferences
Office locations

ICON for

Patients
Volunteers
Investigators
Jobs & Careers
Investors
Suppliers

News & Events

Press releases
Mediakit
Events
Social media dashboard

LinkedIn
Twitter
Facebook
Instagram
Youtube

Disclaimer
Privacy & Data
Cookies

Share this video

Embed

Size: x pixels

Solutions

Sectors

News & Events

About ICON

ICON Webinar Channel

Webinar - Regulatory submission writing for NDA sucess

Share

Related Videos

In Latest Webinars

Webinar: Unlocking precision medicine: An overview of Illumina’s TSO 500

Global Clinical Trials Day: Digital Week - Day 2 Panel

Webinar: Mastering RMPs and RMMs

Webinar: Survival Analysis for Immature Data - A Review of Techniques and Lessons Learned

Artificial Intelligence in Clinical Research

Webinar: Considerations for Oligonucleotide Therapeutics in CMC

Share this video

Embed